Consistent with their function, KRAS-targeting miRNA levels were found to be decreased in CRC, highlighting miRNAs as potential diagnostic or prognostic biomarkers, either as single factors or in miRNA panels [7]. The gene discussed is KRAS; the disease is colorectal carcinoma.